When TME was treated with resveratrol (5 μM) and β1-ASO (0.5 μM), though, E-cadherin expression remained down-regulated because resveratrol could not exert its full epithelial-stabilizing effect in both CRC cell lines (Figures 8A,B). The gene discussed is CDH1; the disease is colorectal carcinoma.